<html><body><h2>Case: 2345853</h2><h3> CDS Time: 1979-10-12</h3>
<patient name=2345853>
79.0 year old Asian_or_Pacific-Islander_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">79</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">89</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">51</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Chloride</td><td width="200">97.0</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">39</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">54</td><td width="200">1979-10-12</td></tr>
<tr><td width="200">B 12</td><td width="200">158</td><td width="200">1978-11-2</td></tr>
<tr><td width="200">Weight</td><td width="200">168</td><td width="200">1979-10-12</td></tr>
<tr><td width="200">HbA1C</td><td width="200">8</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">343</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Urine_ALB/CREAT_RATIO_spot</td><td width="200">11</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Urine_Alb/creat_Ratio_24h</td><td width="200">11</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">142</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">SGOT</td><td width="200">24</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">145</td><td width="200">1979-10-12</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Height</td><td width="200">60</td><td width="200">1979-8-9</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">142</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">BUN</td><td width="200">22</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">HCT</td><td width="200">35</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">HGB</td><td width="200">12</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Sodium</td><td width="200">137</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.3</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">UrineAlbumin_24H</td><td width="200">4</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">8</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">UrineAlbumin_SPOT</td><td width="200">4</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Pulse</td><td width="200">60</td><td width="200">1979-10-12</td></tr>
<tr><td width="200">PLT</td><td width="200">230</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">WBC</td><td width="200">8</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">eGFR</td><td width="200">57</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1979-10-12</td></tr>
<tr><td width="200">SGPT</td><td width="200">36</td><td width="200">1979-9-8</td></tr>
<tr><td width="200">Secondary_Hypertension</td><td width="200"></td><td width="200">1979-9-8</td></tr>
<tr><td width="200">tobacco use</td><td width="200"></td><td width="200">1978-9-9</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1979-4-23</td></tr>
<tr><td width="200">smoking</td><td width="200"></td><td width="200">1978-9-9</td></tr>
<tr><td width="200">Tobacco_Use</td><td width="200"></td><td width="200">1978-9-9</td></tr>
<tr><td width="200">Diabetes with renal manifestations</td><td width="200"></td><td width="200">1978-11-23</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1979-10-12</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1979-10-12</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">onychomycosis</td><td width="200"></td><td width="200">1979-8-11</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1979-10-12</td></tr>
<tr><td width="200">Race</td><td width="200">Asian_or_Pacific-Islander_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1979-10-12</td></tr>
</table>
<p><b>Medications:</b> aspirin(325.0) losartan(100.0) metformin(2000.0) terazosin(1.0) valsartan(325.0) nitrate(60.0) hydrochlorothiazide(25.0) timolol(2.0) Insulin(15.0) glipizide(20.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1979-04-23</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1979-10-12</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Secondary_Hypertension</td>
<td width="200">1979-09-08</td>
<td width="200"> Secondary_Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1978-09-09</td>
<td width="200"> Tobacco_Use()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1979-10-12</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1979-10-12</td>
<td width="200"> DM-Type2()</td></tr>
<tr> <td width="200"></td>
<td width="200">1978-11-23</td>
<td width="200"> Diabetes with renal manifestations()</td></tr>
<tr><td width="200">CCS-1.2</td>
<td width="200">1979-08-11</td>
<td width="200"> onychomycosis()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1979-10-12</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1978-09-09</td>
<td width="200"> tobacco use()
<tr> <td width="200"></td>
<td width="200">1978-09-09</td>
<td width="200"> smoking()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: aspirin Reaction: 
<li>Substance: aspirin Reaction: 
 </ul>
</patient>
<h1 align="center">ATHENA DM: Glycemic Control</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA DM: Glycemic Control: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(diabetes_mellitus)</i>]
</ul>
<b>Scenario choice:</b> Insulin therapy only
<p>
<b>Goal:</b> HBA1C <= target(presence of target HBA1C)
<p><b>Reached goal?</b> failed(HbA1C(8.1/1979-9-8))
<p><b>Action Choices</b>
<ul>
<li><b>DM -  Insulin only</b><br>
<ul>
<li><b>Is patient high risk? If yes, refer <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])


<li><b>Add metformin <font color=FF0000>preferred</font></b>(strict rule-in condition<i> Goal not satisfied</i> evaluate to <b> true</b> because <i>Goal not satisfiedHbA1C(8.1/1979-9-8)</i>)])

</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>Biguanide(METFORMIN)<ul><li><font color=FF0000>Compelling indications:  DM-Type2(DM-Type2) </font><li>Add biguanide, alert hipoxemia, dehydration or sepsis(Withhold metformin in the presence of any condition associated with hipoxemia, dehydration or sepsis.)<li>Biguanide info general(•	Efficacy ( HbA1c) a 1.0 - 2.0%
•	The major blood glucose lowering effect is through decreasing hepatic glucose                           production with some decrease in peripheral insulin resistance 
•	May restore ovulation in premenopausal anovulatory females.
•	Monitor renal function prior to drug initiation and at least annually thereafter.
•	Inexpensive when using generic.)<li>Metformin and B12(Check B12 levels every 2 years when a patient is using Metformin.)<li>preference: preferred</ul></ul></body></html>